Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product (Antisense Oligonucleotides (ASOs), Aptamers, MicroRNAs (miRNAs), Small Interfering RNA (siRNA)), By Applications (Commercial, Academic Research), By End Use, By Region, and Segment Forecasts - 2035

OLIGONUCLEOTIDE SYNTHESIS MARKET REPORT OVERVIEW

The oligonucleotide synthesis market size is expected to grow from USD 3357.43 million in 2025 to USD 3838.21 million in 2026 and is forecast to reach USD 14631.87 million by 2035 at 14.32% CAGR over 2026-2035.

The Oligonucleotide Synthesis Market is a swiftly developing area within the biotechnology enterprise. Oligonucleotides are short DNA or RNA molecules that play crucial roles in numerous research, diagnostic, and therapeutic programs. As call for customized medicinal drug, gene remedy, and molecular diagnostics will increase, so does the need for custom-synthesized oligonucleotides. This marketplace encompasses various services and products, along with synthesizers, reagents, and custom synthesis offerings. Key drivers encompass advancements in synthetic biology, expanding programs in drug discovery, and the growing incidence of genetic issues. The market is characterized with the aid of ongoing technological innovations, which includes high-throughput synthesis techniques and progressed purification techniques. Major gamers in this area consist of both hooked up biotechnology businesses and specialized oligonucleotide manufacturers, competing to meet the growing demand across educational studies, pharmaceutical, and clinical diagnostic sectors.

The United States is the largest market for oligonucleotide synthesis, driven by increasing investments in genomics, molecular diagnostics, precision medicine, and nucleic acid-based therapeutics. Oligonucleotide synthesis is essential for the production of primers, probes, antisense oligonucleotides, siRNA, CRISPR components, and mRNA-based therapeutics used in research, diagnostics, and pharmaceutical development. Rising demand for personalized medicine, next-generation sequencing, and advanced gene therapies is accelerating market growth. Continued investments in automated synthesis platforms, large-scale GMP manufacturing, and high-purity oligonucleotide production continue to strengthen the U.S. oligonucleotide synthesis market.

• • 

    Download Free sample to learn more about this report.

KEY FINDINGS

• Market Size and Growth: The Oligonucleotide Synthesis Market size was USD 2,936.86 Million in 2024, is projected to grow to USD 3,472.21 Million by 2025 and exceed USD 11,195.8 Million by 2033, with a CAGR of 14.32%.

• Key Market Driver: The explosion in genetic research and personalized therapies is fueling demand like never before — in fact, over 62% of biopharma companies now invest in synthetic oligos for drug discovery workflows.

• Major Market Restraint: Raw material shortages and high reagent costs are still a thorn in the side — around 18% of mid-sized labs reported delays in production cycles due to supply inconsistencies in 2023.

• Emerging Trends: Automated DNA/RNA synthesizers are being rapidly adopted — nearly 40% of newly installed gene synthesis systems in 2024 came with AI-assisted protocol optimization for faster turnaround.

• Regional Leadership: North America is ahead of the curve, accounting for 47% of the total market demand in 2024, with the U.S. leading thanks to federal genomics grants and clinical trial volumes.

• Competitive Landscape: It's not a monopoly — over 55 key players are active globally, but just five of them account for close to 60% of global synthesis capacity, thanks to scale and proprietary platforms.

• Market Segmentation: The custom DNA synthesis segment is the most dominant, contributing to nearly 44% of market activity, as precision therapies and CRISPR R&D continue to rise.

• Recent Development: In early 2024, Thermo Fisher launched an advanced oligo production line in Lithuania, expanding their European capacity by 35% — aimed squarely at clinical-grade manufacturing.

COVID-19 Impact

"Pandemic’s Supply Chain Disruptions Led To Temporary Shortages of Products"

The COVID-19 pandemic has been unprecedented and staggering, with Oligonucleotide Synthesis Market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 pandemic had blended consequences at the Oligonucleotide Synthesis Market growth. Negative affects included supply chain disruptions, delays in non-COVID research projects, and decreased laboratory capacity due to lockdowns. Some funding became redirected to COVID-precise tasks, probably affecting demand in positive sectors. Economic uncertainty additionally prompted investment in biotechnology research. However, those bad influences had been partially offset by using improved call for oligonucleotides in COVID-19 diagnostics and vaccine development. The marketplace skilled quick-term disruptions however confirmed resilience and adaptability. As research activities resumed and supply chains stabilized, the sector commenced to get better. Overall, even as the pandemic posed Challenges, it also highlighted the significance of oligonucleotide era in addressing international fitness crises.

LATEST TREND

"Automation and AI in Oligonucleotide Synthesis Helps Market to Grow"

A massive trend within the Oligonucleotide Synthesis Market is the growing integration of automation and synthetic intelligence (AI) technology. Advanced robotics systems are being employed to streamline the synthesis procedure, lowering human error and increasing throughput. AI algorithms are being developed to optimize synthesis protocols, are expecting capability issues, and even design extra effective oligonucleotides for specific applications. This fashion is pushed by way of the developing call for super, huge-scale oligonucleotide manufacturing, particularly within the pharmaceutical and diagnostic industries. Automation and AI not most effective improve performance and decrease fees but also permit greater complicated and unique syntheses. As this technology maintains to conform, it's predicted to noticeably impact the market, probably lowering boundaries to entry and accelerating innovation in oligonucleotide-based totally cures and diagnostics.

• • 

    Download Free sample to learn more about this report.

OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION

By Type

Depending on Oligonucleotide Synthesis Market given are Antisense Oligonucleotides (ASOs), Aptamers, MicroRNAs (miRNAs), Small Interfering RNA (siRNA).

• Antisense Oligonucleotides (ASOs): Short DNA or RNA molecules designed to bind to unique messenger RNA (mRNA) sequences, generally to inhibit gene expression.

• Aptamers: Single-stranded DNA or RNA molecules that could bind especially to goal molecules, regularly used as alternatives to antibodies in numerous programs.

• MicroRNAs (miRNAs): Short, non-coding RNA molecules that modify gene expression post-transcriptionally, playing important roles in numerous biological procedures.

• Small Interfering RNA (siRNA): Double-stranded RNA molecules that cause the degradation of precise mRNA goals, used for gene silencing in research and therapeutic programs.

By Application

The market is divided into commercial, academic research

• Commercial: Encompasses oligonucleotide synthesis for earnings-driven programs, which include pharmaceutical improvement, diagnostic tools, and biotechnology products.

• Academic Research: Involves oligonucleotide synthesis for medical research in universities and studies establishments, focusing on fundamental biological procedures and capacity new programs.

Driving Factors

"Rising Demand for Gene-Based Therapies Drives the Market"

The increasing development and adoption of gene-based totally healing procedures is a major motive force for the Oligonucleotide Synthesis Market. As research in regions together with gene modifying, antisense therapy, and RNA interference advances, the call for custom-synthesized oligonucleotides grows. These healing procedures often require particular, notable oligonucleotides for targeting precise genes or genetic sequences. The ability of these treatments to treat previously untreatable genetic disorders and sure cancers is fueling big funding on this vicinity, immediately boosting the Oligonucleotide Synthesis Marketplace.

"Expanding Applications in Molecular Diagnostics Drives the Market"

The growing area of molecular diagnostics is another key driving force. Oligonucleotides are essential components in numerous diagnostic tools, along with PCR checks, DNA microarrays, and next-technology sequencing. The COVID-19 pandemic highlighted the importance of fast, accurate molecular diagnostics, accelerating tendencies on this field. Beyond infectious sicknesses, oligonucleotide-primarily based diagnostics are increasingly used for early detection of genetic issues, most cancers, and other situations. This expanding software variety is creating sustained demand for synthesized oligonucleotides throughout the healthcare and existence sciences industries.

Restraining Factors

"High Costs and Complexity of Synthesis Restrains the Market Growth"

A restraining issue in the Oligonucleotide Synthesis Market is the excessive fee and complexity related to the synthesis system. Oligonucleotide synthesis requires specialized device, luxurious reagents, and enormously professional employees. The system turns into increasingly complicated and high priced because the period and purity requirements of the oligonucleotides increase. This fee component can restrict accessibility, especially for smaller studies establishments or organizations with limited budgets. It additionally poses Challenges for scaling up production for therapeutic packages, in which big quantities of exquisite oligonucleotides are needed. The complexity of synthesis can result in longer production times and capability fine manipulate troubles, similarly including to costs.

• • 

    Download Free sampleto learn more about this report.

•  

OLIGONUCLEOTIDE SYNTHESIS MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America and Middle East & Africa.

"North America to Dominate the Market due to Superior Studies Infrastructure"

North America is expected to dominate the Oligonucleotide Synthesis Market share due to its superior studies infrastructure, robust pharmaceutical enterprise, and considerable investment for biotechnology. The area boasts international-elegance institutions and corporations riding innovation in gene-based cures and customized medication. Favorable regulatory environments, particularly in the US, encourage the development of oligonucleotide-primarily based merchandise. North America leads in adopting modern technologies like AI and automation in synthesis tactics. The presence of key market gamers and huge public and personal funding in addition solidifies its function. These factors together make sure North America's persevered management in the worldwide Oligonucleotide Synthesis Market, fostering growth and innovation on this important biotechnology region.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage in the Oligonucleotide Synthesis Market"

Key gamers within the Oligonucleotide Synthesis Market are an increasing number of specializing in strategic partnerships to advantage a aggressive part. These collaborations permit businesses to mix their strengths, proportion sources, and boost up innovation. Partnerships often contain joining forces with academic establishments, biotechnology corporations, or pharmaceutical companies to broaden novel synthesis technologies or applications. Such alliances permit businesses to amplify their product portfolios, get admission to new markets, and beautify their studies and development competencies. Collaborations additionally help in addressing complicated demanding situations in oligonucleotide synthesis, consisting of improving scalability and decreasing costs. Additionally, partnerships can cause the improvement of incorporated answers, combining synthesis abilities with downstream applications like drug transport systems.

List of Market Players Profiled

• IDT (Integrated DNA Technologies) (U.S.)
• Genescript (U.S.)
• GeneArt (Thermo Fisher Scientific) (U.S.)
• Genewiz (U.S.)
• SBS Genetech: (China)

INDUSTRIAL DEVELOPMENT

September 2022: An industrial improvement within the Oligonucleotide Synthesis Market is the emergence of big-scale manufacturing abilities. As demand for oligonucleotide-primarily based therapeutics grows, organizations are making an investment in advanced production centres able to synthesizing oligonucleotides at an extraordinary scale. These new facilities utilize current technologies including continuous waft chemistry and automated synthesis structures to dramatically boom production capability whilst maintaining excessive nice requirements. This improvement is vital for meeting the developing demand for oligonucleotides in scientific trials and business treatments. The shift towards large-scale production is likewise driving innovations in purification techniques and high-quality manipulate procedures. This industrial scaling-up is predicted to reduce manufacturing expenses through the years, potentially making oligonucleotide-primarily based remedies extra handy and accelerating their adoption in various therapeutic areas

Five Recent Developments (2023-2025)

• Thermo Fisher Scientific (2023): Expanded its oligonucleotide manufacturing capabilities by investing in high-throughput synthesis technologies and GMP production to support diagnostics, genomics, and therapeutic development.
• Integrated DNA Technologies (IDT) (2024): Enhanced its custom oligonucleotide portfolio by expanding manufacturing capacity and introducing advanced synthesis solutions for CRISPR research, next-generation sequencing, and molecular diagnostics.
• Agilent Technologies (2024): Strengthened its nucleic acid synthesis business by advancing automated oligonucleotide synthesis platforms and high-purity purification technologies for research and clinical applications.
• Eurofins Genomics (2025): Expanded its oligonucleotide production capabilities through investments in large-scale synthesis, quality control, and rapid turnaround services for pharmaceutical and biotechnology customers.
• Danaher (Integrated DNA Technologies) (2025): Advanced its life sciences portfolio by expanding GMP-grade oligonucleotide manufacturing and supporting the development of nucleic acid therapeutics, companion diagnostics, and precision medicine applications.

.

REPORT COVERAGE

The Oligonucleotide Synthesis Market is poised for sizable increase and transformation inside the coming years. Driven by improvements in gene-primarily based treatment options, expanding packages in molecular diagnostics, and the combination of contemporary technologies like AI and automation, the market is turning into increasingly more dynamic and modern. While Challenges which include excessive prices and synthesis complexity persist, ongoing technological traits are regularly addressing these problems. The attention on strategic partnerships amongst key gamers is fostering innovation and increasing market reach. Additionally, the emergence of massive-scale manufacturing talents is about to revolutionize manufacturing tactics and potentially lessen prices.